[Plasma contents of cytokines (TNF-alpha, IL-1 beta, IL-6) and their clearance during continuous hemofiltration in patients with sepsis and multiple organ failure]
- PMID: 9289991
[Plasma contents of cytokines (TNF-alpha, IL-1 beta, IL-6) and their clearance during continuous hemofiltration in patients with sepsis and multiple organ failure]
Abstract
The total-systems inflammatory response was assessed in patients with sepsis and multiple organ failure by measuring plasma cytokines TNF-alpha, IL-1 beta, and IL-6 and their clearance and total elimination in the course of permanent hemofiltration (PHF). Sepsis and multiple organ failure were found to involve a stable circulation of numerous cytokines, their levels reaching the peaks in some cases. No correlation between the content of individual cytokines in the plasma were detected. Appreciable amounts of TNF-alpha and IL-1 beta were eliminated during PHF, their clearance being approximately 15 ml/min, whereas elimination of IL-6 was negligible. Hence, PHF affects the mediator component in the pathogenesis of sepsis and the multiple organ failure syndrome.
Similar articles
-
[Effect of continuous veno-venous hemofiltration on the plasma level of cytokines in patients with multiple organ dysfunction syndrome].Zhonghua Wai Ke Za Zhi. 2006 Sep 1;44(17):1197-9. Zhonghua Wai Ke Za Zhi. 2006. PMID: 17147866 Chinese.
-
[High-volume hemodiafiltration in the treatment of sepsis and multiple organ failure: 2 methods of the elimination of TNF-alpha].Anesteziol Reanimatol. 2001 Mar-Apr;(2):46-8. Anesteziol Reanimatol. 2001. PMID: 11494901 Russian.
-
[Tumor necrosis factor-alpha kinetics during renal replacement therapy in patients with sepsis and multiple organ failure].Ter Arkh. 1997;69(11):38-9. Ter Arkh. 1997. PMID: 9483744 Russian.
-
Removal of mediators by continuous hemofiltration in septic patients.World J Surg. 2001 May;25(5):651-9. doi: 10.1007/s002680020027. Epub 2001 Apr 12. World J Surg. 2001. PMID: 11369995 Review.
-
Development of sorbent therapy for multiple organ dysfunction syndrome (MODS).Biomed Mater. 2007 Jun;2(2):R12-6. doi: 10.1088/1748-6041/2/2/R02. Epub 2007 Mar 27. Biomed Mater. 2007. PMID: 18458435 Review.
Cited by
-
Prophylactic simvastatin treatment modulates the immune response and increases survival of mice following induction of lethal sepsis.J Int Med Res. 2019 Aug;47(8):3850-3859. doi: 10.1177/0300060519858508. Epub 2019 Jul 16. J Int Med Res. 2019. Retraction in: J Int Med Res. 2024 Jan;52(1):3000605241228165. doi: 10.1177/03000605241228165. PMID: 31307265 Free PMC article. Retracted.
-
Plasma cytokine response in mice with bacterial infection.Mediators Inflamm. 2000;9(5):229-34. doi: 10.1080/09629350020025746. Mediators Inflamm. 2000. PMID: 11200363 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical